Skip to content

Ketones and Muscle Protein Synthesis

The Effects of Acute Nutritional Ketosis on Myofibrillar Protein Synthesis in Young Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04565444
Enrollment
36
Registered
2020-09-25
Start date
2020-09-21
Completion date
2021-05-14
Last updated
2021-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketosis, Regulation of Muscle Protein Synthesis

Keywords

ketone, protein metabolism, muscle

Brief summary

Ketones are natural substances normally produced by the body during prolonged fasting and starvation, or in response to a ketogenic diet to be used as fuel by the brain and muscles. Ketones are therefore similar to dietary proteins, carbohydrates and fats since they represent a source of energy for the body. In addition to serving as a source of energy, ketones have also been shown to stimulate increased rates of muscle protein synthesis in humans. The ingestion of dietary protein is well established to stimulate an increase in the rate of protein synthesis in skeletal muscle. The rate of muscle protein synthesis can be maximized following the intake of 20g of protein. As a result, smaller doses of protein (i.e. 10g) represent a sub-optimal dose of protein because there is still room for improvement concerning muscle protein synthesis. Recently ketone-containing food products have become available that elevate ketone levels in the body without the need for ketogenic diets or prolonged fasting. Therefore, the purpose of this study is to measure skeletal muscle protein synthesis rates after ingesting the following: 1. Ketone monoester 2. Ketone monoester supplemented with sub-optimal dose of whey protein 3. Sub-optimal dose of whey protein It is hypothesized that muscle protein synthesis rates will increase following the ingestion of a ketone-containing beverage. Further, muscle protein synthesis rates will be enhanced when the ketone-containing beverage and sub-optimal protein dose are taken together.

Interventions

DIETARY_SUPPLEMENTKetone

* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * Isocaloric carbohydrate control: dextrose + vanilla flavouring

DIETARY_SUPPLEMENTKetone + Protein

* Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight) * 10g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

DIETARY_SUPPLEMENTProtein

* Isocaloric carbohydrate control: dextrose + stevia * 10g Whey Protein * L-\[ring-2H5\]-phenylalanine tracer (enriched to 4%)

Sponsors

McGill University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Aged between 18-35 years inclusive * Healthy, moderately active * BMI \< 30 kg/m2 and \> 18.5 kg/m2 * Having given informed consent

Exclusion criteria

* Presence of any identified metabolic or intestinal disorders * Use of tobacco products * Allergies to milk proteins (whey or casein) * Lactose intolerance * Phenylketonuria (PKU) * A history of neuromuscular problems * Previous participation in amino acid tracer studies * Adherence to a strict vegetarian or vegan diet * Current use of ketone supplements or adherence to a ketogenic diet * Use of medications known to affect protein metabolism * Diagnosis of Diabetes * Engagement in sports or physical exercise 5 or more days per week

Design outcomes

Primary

MeasureTime frame
Fractional synthetic rate of muscle protein synthesis (myofibrillar)0-5 hours in the post-prandial period

Secondary

MeasureTime frameDescription
Plasma enrichments (in moles percent excess) of L-[ring-2H5]-phenylalanine3 hours pre-prandial to 5 hours post-prandial
Plasma glucose concentration (mmol/L)3 hours pre-prandial to 5 hours post-prandial
Plasma insulin concentration (pmol/L)3 hours pre-prandial to 5 hours post-prandial
Fractional synthetic rate of muscle protein synthesis (myofibrillar)0-3 hours in the pre-prandial period; 0-2 hours, and 2-5 hours into the post-prandial period
Capillary blood Beta-OHB concentrations (mmol/L)0-5 hours in the post-prandial period
Signaling molecule phosphorylation status0, 2, and 5 hours into the post-prandial periodThe use of Western blots to measure the phosphorylation status of signaling molecules involved in protein synthesis ie. mTOR, p70S6k, 4E-BP1
Plasma amino acid concentrations (mmol/L)3 hours pre-prandial to 5 hours post-prandial

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026